Fortress Biotech, Inc.FBIONASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank79
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.92
↑ 56% vs avg
Percentile
P79
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-2.07
Historical baseline
PeriodValueYoY Change
2024-0.92-127.8%
2023-0.40+40.6%
2022-0.68+78.5%
2021-3.16+35.6%
2020-4.91-39.4%
2019-3.52-692.2%
2018-0.44+82.1%
2017-2.49-26.9%
2016-1.96+13.2%
2015-2.26-